Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 12, 2025

Dec. 12, 2025

Alameda Health System reminds community: Apply for Medi-Cal before December 31, 2025

GlobeNewswire

Dec. 12, 2025

Extendicare Announces December 2025 Dividend of C$0.042 per Share

GlobeNewswire

Dec. 12, 2025

Teva Releases Q4 2025 Aide Memoire

GlobeNewswire

Dec. 12, 2025

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

GlobeNewswire

Dec. 12, 2025

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 12, 2025

Edesa Biotech Reports Fiscal Year 2025 Results

GlobeNewswire

Dec. 12, 2025

4DMT Announces New Employment Inducement Grants

GlobeNewswire

Dec. 12, 2025

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 12, 2025

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

GlobeNewswire

Dec. 12, 2025

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 12, 2025

GRI Bio Announces Closing of $8.0 Million Public Offering

GlobeNewswire

Dec. 12, 2025

NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways

GlobeNewswire

Dec. 12, 2025

Park Dental Partners Rings the Closing Bell on the Nasdaq in New York

GlobeNewswire

Dec. 12, 2025

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial

GlobeNewswire

Dec. 12, 2025

Decking the Halls: 13th Annual Christmas Tree Giveaway Delivers Holiday Joy to More Than Families in Need

GlobeNewswire

Dec. 12, 2025

FDA Approves Amgen’s UPLIZNA® (inebilizumab-cdon) for Generalized Myasthenia Gravis (gMG), Expanding Treatment Options for Patients Living with Autoimmune Neuromuscular Disease

GlobeNewswire

Dec. 12, 2025

Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup

GlobeNewswire

Dec. 12, 2025

Lessing’s Hospitality Group Partners with Catholic Health to Launch Shoreline Café Across Long Island Hospitals

GlobeNewswire

Dec. 12, 2025

Anavar Steroid 2026: Legal Steroid Alternative, Anavar For Women Cycle, Dosage, Side Effects, Anavar Before And After Result (Anavar for Sale) Launch Alternative Anvarol By CrazyBulk

GlobeNewswire

Dec. 12, 2025

Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain

GlobeNewswire